Related Experiment Videos
Blood infectivity in transmissible spongiform encephalopathies
1Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark. dickmeis@rh.dk
Summary
Transmissible spongiform encephalopathies (TSE) can infect blood, with variant Creutzfeldt-Jakob disease (vCJD) potentially spreading via blood transfusions. While transmission is biologically plausible, it appears extremely rare, necessitating precautionary measures.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases.
- Blood infectivity is a known characteristic of some TSEs.
- The risk of transfusion-transmitted TSEs, particularly variant Creutzfeldt-Jakob Disease (vCJD), is a public health concern.
Purpose of the Study:
- To review the infectivity of blood in transmissible spongiform encephalopathies (TSEs).
- To specifically evaluate the risk of vCJD transmission through blood transfusion.
- To discuss precautionary measures against potential vCJD transmission via blood products.
Main Methods:
- Literature review focusing on blood infectivity in TSEs.
- Analysis of existing data on vCJD transmission routes.
- Discussion of public health strategies and risk mitigation.
Main Results:
- Blood transfusion is a biologically plausible route for vCJD transmission.
- Current evidence suggests that vCJD transmission via blood transfusion is extremely uncommon.
- The review highlights the need for ongoing vigilance and precautionary measures.
Conclusions:
- While vCJD transmission through blood transfusion is theoretically possible, the actual risk appears very low.
- Precautionary measures are essential to mitigate the potential, albeit rare, risk of vCJD transmission.
- Further research and surveillance are warranted to fully understand and manage transfusion-transmitted vCJD risk.